SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-089329
Filing Date
2017-03-20
Accepted
2017-03-20 16:10:03
Documents
3
Period of Report
2017-03-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d362479d8k.htm 8-K 15842
2 EX-23.1 d362479dex231.htm EX-23.1 2047
3 EX-99.1 d362479dex991.htm EX-99.1 8554
  Complete submission text file 0001193125-17-089329.txt   27544
Mailing Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121
Business Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36282 | Film No.: 17701509
SIC: 2836 Biological Products, (No Diagnostic Substances)